Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Eli-Lilly
Company Monitoring Page for Eli-Lilly
latest headlines for company on cafepharma
The biggest launches of 2022: a reboot
EP Vantage
Mon, 02/14/22 - 10:48 am
Tags:
drug launches
,
Eli Lilly
,
tirzepatide
,
Alnylam
,
vutrisiran
,
Roche
,
Vabysmo
,
JNJ
,
Carvykti
,
Mirati Therapeutics
,
adagrasib
,
Bristol Myers Squibb
,
mavacamten
,
deucravacitinib
Lilly back in COVID-19 antibody game with $720 million deal with U.S. for omicron-busting hopeful
Fierce Pharma
Fri, 02/11/22 - 11:48 am
Tags:
Eli Lilly
,
monoclonal antibodies
,
COVID-19
,
bebtelovimab
FDA sends signal with tough questions of Lilly at cancer drug meeting
BioPharma Dive
Thu, 02/10/22 - 10:37 pm
Tags:
Eli Lilly
,
Innovent Biologics
,
lung cancer
,
clinical trials
,
China
Neuro-focused Arkuda raises $64M as dementia drug moves closer to the clinic
MedCity News
Thu, 02/10/22 - 10:22 am
Tags:
Arkuda Therapeutics
,
Eli Lilly
,
funding
,
dementia
Eli Lilly, Innovent's PD-1 in troubled waters as FDA review, oncology chief's comments portend likely rejection
Fierce Pharma
Wed, 02/9/22 - 10:56 am
Tags:
Eli Lilly
,
Innovent
,
Tyvyt
,
PD-1 inhibitors
COVID-19 treatments earned 4 drugmakers $14B in 2021
Beckers Hospital Review
Tue, 02/8/22 - 11:50 pm
Tags:
Eli Lilly
,
Gilead Sciences
,
Merck
,
Regeneron
,
COVID-19
,
earnings
Endeavor Bio adds $101M to test ex-Eli Lilly, Roche drug in cancer & lung fibrosis
MedCity News
Tue, 02/8/22 - 09:52 am
Tags:
Endeavor BioMedicines
,
taladegib
,
cancer
,
Eli Lilly
,
Roche
,
idiopathic pulmonary fibrosis
Lilly slows FDA submission of Alzheimer's drug after Medicare decision
BioPharma Dive
Thu, 02/3/22 - 11:43 pm
Tags:
Eli Lilly
,
donanemab
,
Alzheimer's disease
Eli Lilly (LLY) Q4 Earnings Miss, COVID Therapies Aid Sales
Yahoo/Zacks.com
Thu, 02/3/22 - 11:41 pm
Tags:
earnings
,
Eli Lilly
Eli Lilly Announces Nearly $1.5 Billion Investment into New Manufacturing Facilities in North Carolina and Ireland
Xtalks
Thu, 02/3/22 - 10:57 am
Tags:
Eli Lilly
,
drug manufacturing
,
Ireland
,
North Carolina
CMS' Biogen decision could spell problems for Lilly, Roche Alzheimer's drugs, half of surveyed neurologists say
Fierce Pharma
Tue, 02/1/22 - 10:50 am
Tags:
CMS
,
Biogen
,
Aduhelm
,
Eli Lilly
,
Roche
,
Alzheimer's disease
Eli Lilly, Incyte axe Olumiant in lupus amid eczema stalemate at FDA
Fierce Pharma
Fri, 01/28/22 - 11:47 am
Tags:
Eli Lilly
,
Incyte
,
olumiant
,
FDA
,
lupus
,
eczema
Eli Lilly plans €400m Irish plant that will create 800 jobs
Pharmaforum
Fri, 01/28/22 - 10:13 am
Tags:
Eli Lilly
,
Ireland
,
biologics
,
drug manufacturing
FDA bans use of Lilly, Regeneron COVID drugs due to Omicron
Pharmaforum
Tue, 01/25/22 - 10:44 am
Tags:
COVID-19
,
Eli Lilly
,
Regeneron
,
antibodies
,
Omicron COVID-19 variant
Trulicity Instagram post draws OPDP’s first untitled letter of 2022
RAPS.org
Mon, 01/24/22 - 11:37 pm
Tags:
Eli Lilly
,
Trulicity
,
OPDP
,
FDA
,
social media
Confidence is high for Eli Lilly CEO Ricks in showdown with Biogen's Aduhelm
Fierce Biotech
Fri, 01/21/22 - 11:13 am
Tags:
Eli Lilly
,
Biogen
,
Alzheimer's disease
,
Aduhelm
,
donanemab
,
clinical trials
,
David Ricks
Eli Lilly lines up metabolic pacts with Evotec, Abbisko as it awaits diabetes med nod from FDA
Fierce Biotech
Tue, 01/18/22 - 11:49 pm
Tags:
Eli Lilly
,
Evotec
,
Abbisko Therapeutics
,
diabetes
Two new drugs added to WHO list of COVID-19 therapies
Pharmaforum
Mon, 01/17/22 - 10:26 am
Tags:
WHO
,
COVID-19
,
Eli Lilly
,
olumiant
,
GSK
,
Vir Biotechnololgy
,
sotrovimab
Biotech investors pray for a takeover miracle
EP Vantage
Fri, 01/14/22 - 11:09 am
Tags:
M&A
,
biotech
,
Amylyx Pharmaceuticals
,
Arena Pharmaceuticals
,
AstraZeneca
,
Aurinia Pharmaceuticals
,
Biogen
,
Biohaven
,
Bristol Myers Squibb
,
Eli Lilly
,
GSK
,
Merck
,
Novartis
,
Novo Nordisk
,
Pfizer
,
Sanofi
7 drugs likely to hit $1B in annual revenue in the next 5 years
Beckers Hospital Review
Thu, 01/13/22 - 07:31 am
Tags:
FDA
,
adagrasib
,
donanemab
,
faricimab
,
lecanemab
,
tezepelumab
,
tirzepatide
,
vutrisiran
,
Eli Lilly
,
Mirati Therapeutics
,
Roche
,
Chugai
,
Eisai
,
Biogen
,
AstraZeneca
,
Amgen
,
Alnylam
Pages
« first
‹ previous
…
25
26
27
28
29
30
31
32
33
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.